Background
In response to an expanding generalized HIV epidemic in the early 1990s, Thailand implemented wide-scale national HIV education efforts and a 100% condom use campaign among sex workers and their clients that successfully controlled heterosexual HIV transmission (Kilmarx et al., 2000; Nelson et al., 1996) ; however, a cross-sectional survey among men who have sex with men (MSM) in Bangkok in 2003 found an HIV prevalence of 17% (van Griensven et al., 2005) and HIV prevalence in follow-up biennial surveys done in 2005 through 2012 ranged from 25% to 31% (Kladsawas, Kittisunrobus, Tjarupun, Namwat, & Plipat, 2010 ; Results of venue-based HIV surveillance among men who have sex with men in Thailand, 2012 . [In Thai], 2012 ) . High HIV incidence rates among MSM have also been reported in Bangkok; among 8,176 MSM seeking HIV testing at the Silom Community Clinic 2006-2013, HIV incidence was 5.5 per 100 person-years and among 1,744 MSM enrolled in a cohort study at the clinic, incidence was 5.3 per 100 person-years (van Griensven et al., 2015) . Epidemic modeling based on these studies and other data suggests that 43% of new HIV infections in Thailand in 2015 occurred among MSM (Thailand National Operational Plan Accelerating Ending AIDS 2015-2019. Thailand National AIDS Committee, 2014). Despite high HIV prevalence and incidence among MSM, the uptake of HIV testing is low; only half of 1,575 MSM surveyed in 2005 in Bangkok, Chiang Mai, and Phuket said they had had an HIV test (Wimonsate et al., 2011) and only one-fourth of those tested had returned to receive their HIV test result. In 2012, an analysis of data collected by the Global Fund for AIDS, Tuberculosis, and Malaria (Global Fund) showed that only 7% of MSM in Thailand who received a package of HIV educational and prevention services opted for an HIV test (Wolf, 2012) . Similarly, a 2014 integrated biomedical and behavioral survey (IBBS) among MSM in Thailand found that only one-third of MSM had been tested for HIV and knew their result (Supiya Jantaramanee, 2014) . These data suggest that many HIVinfected MSM have missed opportunities to be diagnosed and receive treatment, and, unaware of their HIV status, may transmit HIV to their sexual partners.
HIV testing is the entry point to access Test and Treat services and PrEP, and increasing HIV testing among people at high risk of infection is an important goal of Thailand's National Operational Plan for Ending AIDS 2015-2019 (Thailand National Operational Plan Accelerating Ending AIDS 2015-2019. Thailand National AIDS Committee, 2014) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) (Technical Guidance on Combination HIV Prevention 2011). Several promising tools and strategies including rapid HIV tests and mobile and peer-led HIV testing services (HTS) have been found to be acceptable among populations at high risk of HIV and have been used to expand HIV testing (Lorenc et al., 2011; Shangani et al., 2017; Sharma, Ying, Tarr, & Barnabas, 2015) .
With an aim to strengthen HTS and increase HIV testing among MSM, the Thailand Ministry of Public Health (MOPH), the U.S. Centers for Disease Control and Prevention (CDC), and PEPFAR, in collaboration with Provincial Health Offices (PHO) in Thailand, and the Global Fund launched a package of HIV prevention activities in four provinces with high HIV prevalence in Thailand. Started in late 2011, the HIV prevention program for MSM (PREV) aimed to increase HIV testing, ensure that people tested received their results, and that those who tested HIV-positive were linked to care. This was done using a combination of peer-led counseling and referrals to facilities that had received sensitivity training and non-facility-based HTS. The HTS used rapid HIV tests providing same-day test results and immediate referral to care consistent with Thailand's national HIV treatment guideline. During the initial program rollout, staff recognized that TG women were interested in and in need of services and TG women were included in the program. This manuscript describes the outcomes of the PREV program from September 2011 (the beginning of 2012 fiscal year) through August 2016 (end of the 2016 fiscal year).
Methods

PREV program activities
We trained MSM and TG women outreach peer-educators who worked with a local community-based organization to: identify sites where MSM and TG women would come for HIV testing (i.e., target mapping), provide HIV education and information about HIV testing, identify people at high risk of HIV infection (i.e., reported having anal intercourse without using a condom), provide behavior change information, and refer people for HIV testing at mobile sites and hospital clinics. We identified four public hospital clinics serving MSM populations interested in participating in the PREV program and provided clinic staff supplemental training on health care management for MSM, sensitivity to sexual diversity, risk reduction counseling and condom use, and rapid HIV testing. We worked with clinic staff and peer-educators to implement mobile HTS, as an extension of hospital activities, in areas popular among MSM and TG women identified through target mapping. The program provided mobile HTS once every one to two months at sites such as musical events, peer houses where MSM congregated, community-organized sports tournaments, and entertainment events such as MSM dance contests. Clients who tested HIV-positive at mobile-clinic sites received counseling and referral to HIV care and treatment services from hospital nursecounselors. In Thailand, baseline laboratory tests including CD4 count are done once the person has registered for care at their designated hospital; therefore, we used the CD4 test result as a marker of linkage to care.
We used rapid HIV tests to provide same-day HIV test results using a 3-test HIV testing algorithm consistent with Thailand's national HIV testing guideline ("Thailand National Guidelines on HIV/AIDS Treatment and Prevention 2014," 2014). Clients were screened using Alere Determine™ HIV-1/2 (Alere Medical Co., Ltd., Japan), and reactive results were confirmed with DoubleCheck-Gold™ Ultra HIV-1/2 (ORGENICS Co., Ltd, Israel) and SD Bioline HIV 1/2 3.0 (Standard Diagnosis, Inc. South Korea). All participants provided informed consent prior to HIV testing consistent with government policy.
Clinic settings
Four public hospitals participated in the PREV program. Bangrak Hospital, the national reference center for sexually transmitted infection (STI) services, is located in central Bangkok and is managed by the Thailand MOPH. The hospital provides STI testing, diagnosis, and treatment services. HIV testing is offered to all STI clients but the clinic does not provide HIV treatment services. Napha Clinic is a one-stop HIV and STI clinic in the Udonthani Provincial Hospital in Udonthani Province. The clinic provides HIV and STI testing, diagnosis, and treatment services including ART, and has a dedicated laboratory and pharmacy on-site. Plai Fah Clinic is a primary care clinic affiliated with Khon Kaen Provincial Hospital in Khon Kaen Province. The clinic provides HIV and STI testing, diagnosis, and treatment services. Clients who test HIV-positive at Plai Fah are referred to Khon Kaen Provincial Hospital or to the hospital where the client is registered for HIV care and treatment. Sabaidee Clinic is an MSM and TG-friendly HIV and STI testing site in the Patong Community Hospital in Phuket Province. Clients who test HIV-positive can receive HIV care at treatment services at Patong Community Hospital; CD4 count and viral load testing are done at the Phuket Provincial Hospital.
Data collection and analysis
As part of the pre-test counseling process, staff used a standardized counseling check-list to collect client demographic characteristics, recent HIV associated sexual risk activity, and HIV testing history. Gender identity (e.g., MSM or TG) were self-identified by program participants. Staff entered data in Access (Microsoft Office 2013, Washington, USA) and we used SAS version 9.3 (SAS Institute, North Carolina, USA) for statistical analyses.
Program activities were funded by fiscal year (FY) (i.e., 1 September 2011-31 August 2012 = FY2012) starting 1 September 2011 and ending 31 August 2016 (i.e., FY2012 to FY2016). Therefore, we used FYs to describe time in the analysis.
We used Poisson regression and Wilcoxon rank sum trend tests to determine trends over time and chi-square tests and Cochran-Mantel Haenzel tests for categorical variables. We assessed factors associated with the site of HIV testing (i.e., hospital clinic or mobile clinic) using chi-square tests for dichotomous variables and Wilcoxon rank sum tests (for median) for continuous variables.
HIV incidence was calculated per 100 person-years of observation, using data from participants who initially tested HIV-negative and tested at least one more time, assuming a uniform probability distribution throughout the interval between the last negative and first positive HIV tests (Kitayaporn et al., 1994) . Confidence intervals for HIV incidence rates were calculated using the Exact Poisson method.
Ethical review
This activity was approved as a non-research program evaluation by CDC, Center for Global Health.
Results
Participant characteristics
From September 2011 (FY2012) through August 2016 (FY2016), 5,730 participants received HIV pre-test counseling; 5,629 (98%) decided to have an HIV test done, and 5,609 (99.6%) received their HIV result. The median age of people tested was 24 years, 4,119 (73%) identified as MSM, 818 (15%) reported they were MSW, and 692 (12%) identified as TG women. Most (i.e., 96%) participants were single, 95% reported that their most recent sexual exposure was with a man, and 63% reported they used a condom during their most recent sexual encounter ( Table 1) .
The number of people testing increased from 458 in FY2012 to 1,832 in FY2016 (p < 0.001) ( Table 1) . Among those who had an HIV test done, 2,299 (41%) had learned about the PREV program from peer educators: the proportion referred by peer educators increased from 18% in FY2012 to 53% in FY2013 then declined to 32% in FY2016. Peer educators referred 72% of those tested for HIV in Khon Kaen and 60% of those tested in Phuket, but only 29% in Udonthani and 28% in Bangkok (data not shown).
HIV and CD4 test results
Overall, 3,412 (61%) participants were testing for the first time and the proportion testing for the first time increased from 40% in FY2012 to 65% in FY2016 (p < 0.001, Table 1 ). About one-third (i.e., 34%) of participants had their HIV test done at a mobile clinic site and the number tested at mobile sites increased from 21 (5% of those testing) in FY2012 to 705 (38% of those testing) in FY2016.
Of those tested for HIV from FY2012 through FY2016, 1193 (21%) tested positive; the proportion testing HIVpositive increased from 21% in FY2012 to a peak of 27% in FY2014 and then declined to 17% in FY2016 (Table 1) . Cumulative HIV prevalence was highest among participants in Udonthani (25%) and Bangkok (24%) and lower in Phuket (16%) and Khon Kaen (13%) (data not shown). Cumulative HIV prevalence was highest among those who identified as MSW (25%) and MSM (22%) and lower in TG women (12%) (data not shown).
CD4 count results were available for 756 (63%) of the 1193 people who tested HIV-positive (Table 1) . The median CD4 count at diagnosis was 284 cells/mm 3 and did not change significantly from FY2012 through FY2016.
HIV incidence
From FY2012 to FY2016, 68 (7%) of 925 people who initially tested HIV-negative and returned for at least one additional HIV test, tested positive, yielding an HIV incidence of 6.2 per 100 person-years (95% confidence interval [CI] 4.8-7.9) ( Table 2) . HIV incidence was highest in Bangkok (7.5 per 100 person-years) and Udonthani (5.8 per 100 person-years), and lower in Phuket (4.6 per 100 person-years) and Khon Kaen (3.3 per 100 person-years). HIV incidence was higher among participants ≤ 24 years old (10.9 per 100 person-years among people 20-24 years old and 10.8 among those ≤ 19 years old) than those who were > 24 years old (3.8 per 100 person-years). HIV incidence was 8.1 per 100 person-years among MSW, 6.0 among MSM, and 4.1 among TG women. HIV incidence declined from 20.0 per 100 person-years (95% CI 10.3-34.9) in FY2012-2013 (data for FY2012 and 2013 were combined because there were only 12 person-years of follow-up in FY2012) to 4.0 per 100 person-years (95% CI 2.5-6.0) in FY2016.
HIV testing sites
Compared with participants who had HIV testing at hospital clinics, participants tested at mobile clinics were younger, more likely to have been referred by peers, and more likely to be testing for HIV for the first time (all p < 0.001) (Table 3) . Participants tested at hospital clinics were more likely to be HIV-positive (25%) at baseline than those tested in mobile clinics (13% HIV-positive) (p < 0.001) and, among those who tested HIV-positive, the median CD4 count of those tested at the mobile clinics (356 cells/mm 3 ) was higher than those tested at the hospital clinics (278 cells/mm 3 ) (p = 0.003).
Discussion
We successfully implemented a program to increase HIV testing among MSM and TG women at mobile and clinic-based sites in four provinces of Thailand. We trained hospital and clinic staff on sexual diversity, sensitive risk reduction counseling strategies, and rapid HIV testing. Peer educators worked with clinic staff to provide rapid HIV testing and results at the hospitals and clinics or at mobile HIV testing sites positioned based on target mapping. The number of people tested increased from 458 in FY2012 to 1832 in FY2016 and > 99% of people tested received their HIV result and were counseled about their HIV status. The proportion of people referred by peer educators and the proportion testing at mobile-clinic sites increased from FY2012 to FY2016.
The HIV prevalence among those tested was high, 17% in FY2016, and although HIV incidence declined from FY2012 to FY2016, incidence remained high: 6.2 per 100 person-years overall and 10.8 per 100 personyears in people ≤ 19 years old. These data confirm and add to previous surveys and cohort studies that have documented high HIV prevalence and incidence rates among MSM in Bangkok ("Errata," 2013; Thienkrua et al., 2017; van Griensven et al., 2015; van Griensven et al., 2010) . Interestingly, HIV prevalence and incidence among TG women, although high, was lower than the prevalence and incidence among MSM and MSW. Other study has found higher HIV prevalence among TG women worldwide (Baral et al., 2013) . The PREV program did not specifically target TG women for recruitment and testing and more work is needed to fully describe HIV prevalence and incidence and risks of TG women in Thailand. Nonetheless, the high prevalence and incidence we found among MSM, MSW, and TG women confirms an ongoing epidemic of HIV among these populations and highlights the need for more effective and targeted HIV prevention interventions.
We found that mobile HIV testing services were an effective tool to reach high-risk MSM and TG women. Previous studies have shown that mobile clinics can expand access to HIV testing particularly among people at high risk of HIV infection (Vial, Starks, & Parsons, 2014) . In the PREV program, people testing at mobile clinics were younger and more likely to be testing for the first time than people testing at hospital clinics. Increasing the number of mobile clinics that can provide rapid HIV testing at convenient times and places may help bring more HIV-infected MSM and TG women into care and treatment services.
Consistent with other studies , people diagnosed with HIV infection at mobile clinics had higher baseline CD4 counts than those diagnosed at hospital clinics, suggesting that mobile clinics were reaching people earlier in their HIV illness when ART can reduce the risk of serious illness and death and limit ongoing HIV transmission (Beyrer, Bekker, Pozniak, & Barre-Sinoussi, 2015; Cohen et al., 2011;  2015) . In the PREV program, a similar proportion (i.e., 63%) of HIV-positive clients were registered for care in the National AIDS Program (NAP) and received baseline CD4 testing. We were not able to access confidential NAP data of those who did not register for care at the time of diagnosis to determine if they may have registered at other hospitals ("Management manual for HIV/AIDS fund", 2016). Additional work needs to be done in Thailand to identify and implement strategies to actively link PLHIV to care and treatment services immediately after HIV diagnosis.
In the PREV program, MSM and TG women peers worked closely with health care providers and provincial health officers to conduct target mapping, plan mobile HTS, and refer MSM and TG women to HIV testing services. Peer involvement expanded access to young high-risk MSM and TG women. Other studies have shown that peers can be trained to provide rapid HIV screening test, link those who test HIV-positive to confirmatory testing services and HIV care, and support PLHIV to remain in care (Becky L. Genberg, 2016; Hongjing Yan et al., 2014) . The WHO recommends that trained and supervised lay providers provide HIV testing and ART (WHO, 2016), suggesting that peers can have a larger role in the provision of HIV services. However, expanding the role of lay providers will require training, development of accreditation standards, and in some settings, regulatory approval.
Our program assessment has several limitations. We analyzed results from people who participated in the program and did not have a comparison group. The HIV prevalence, incidence, and HIV associated risk behaviors of MSM and TG women who did not participate in the PREV program may differ from those who participated. Some people diagnosed with HIV in our program did not register for care at the time of diagnosis, preventing us from ascertaining if they received ART and remained in the care. In addition, we used CD4 count test as proxy for linkage to care. Although the test is provided at the hospital once the PLHIV registers for care, receiving a CD4 count test does not necessarily signify that the PLHIV received ARV treatment.
In conclusion, a program to recruit MSM and TG women for rapid HIV testing through a combination of clinic-based and well-targeted mobile HIV testing, and peer-referral, can reach high-risk MSM and TG women including those who have not had HIV testing. HIV incidence rates remain alarmingly high, especially among young MSM and TG women. A substantial proportion of those who tested HIV-positive were not immediately linked to care and treatment services and may have been lost to follow-up. Efforts to ensure that people who test HIV-positive are offered ART and that those at high risk of HIV infection who test HIVnegative are offered prevention services including PrEP will help Thailand end AIDS by 2030, the goal of the National AIDS Strategy.
